Giulia Di Lazzaro

UCL Queen Square Institute Of Neurology
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

Is continuous dopaminergic delivery still a major goal to be achieved in the treatment of Parkinson's disease?

Is continuous dopaminergic delivery still a major goal to be achieved in the treatment of Parkinson's disease?

Journal: Journal of Parkinson's disease

Published: July 10, 2026

A Novel RORA Hinge-Region Variant in Adult IDDECA With Cerebellar Atrophy and Marked Response to Valproate.

A Novel RORA Hinge-Region Variant in Adult IDDECA With Cerebellar Atrophy and Marked Response to Valproate.

Journal: European journal of neurology

Published: April 08, 2026

Association between plasma glucosylsphingosine levels and dyskinesia burden in GBA1-related Parkinson's disease.

Association between plasma glucosylsphingosine levels and dyskinesia burden in GBA1-related Parkinson's disease.

Journal: Neurobiology of disease

Published: November 22, 2025

Predictive value of cerebrospinal fluid Alzheimer's disease biomarkers and neuropsychological measures for cognitive and motor outcomes in Parkinson's disease.

Predictive value of cerebrospinal fluid Alzheimer's disease biomarkers and neuropsychological measures for cognitive and motor outcomes in Parkinson's disease.

Journal: Brain communications

Published: September 21, 2025

Physical exercise modulates plasma irisin levels in endurance athletes: Implications for Parkinson's disease.

Physical exercise modulates plasma irisin levels in endurance athletes: Implications for Parkinson's disease.

Journal: Neurobiology of disease

Published: July 28, 2025

CSF phospho-tau levels at Parkinson's disease onset predict the risk for development of motor complications.

CSF phospho-tau levels at Parkinson's disease onset predict the risk for development of motor complications.

Journal: Journal of neurology

Published: July 10, 2025

Are we ready for a biological diagnosis of Parkinson's Disease?

Are we ready for a biological diagnosis of Parkinson's Disease?

Journal: Cell death & disease

Published: May 22, 2025

Effect of aging on biomarkers and clinical profile in Parkinson's disease.

Effect of aging on biomarkers and clinical profile in Parkinson's disease.

Journal: Journal of neurology

Published: April 15, 2025

T1-reverse Eye of the Tiger sign in acquired hepatocerebral degeneration.

T1-reverse Eye of the Tiger sign in acquired hepatocerebral degeneration.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: March 10, 2025

Ataxia-Telangiectasia Presenting as Tremor-Predominant Syndrome in an Adult Patient without Ataxia and Telangiectasias.

Ataxia-Telangiectasia Presenting as Tremor-Predominant Syndrome in an Adult Patient without Ataxia and Telangiectasias.

Journal: Movement disorders clinical practice

Published: December 13, 2024

Abnormal arm swing movements in Parkinson's disease: onset, progression and response to L-Dopa.

Abnormal arm swing movements in Parkinson's disease: onset, progression and response to L-Dopa.

Journal: Journal of neuroengineering and rehabilitation

Published: November 29, 2024

An early feasibility study for neurological devices: The ARCTRAN study.

An early feasibility study for neurological devices: The ARCTRAN study.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: August 04, 2024

Showing 1-12 of 68

Last Updated: 09/26/2026